0 Replies
Stories include:
Back in 2008, an excited Pfizer shelled out $40 million upfront and agreed to make a $10 million equity investment in exchange for the worldwide rights to Celldex's CDX-110 (rindopepimut), a promising brain cancer vaccine. But by last September, that therapy no longer fit into Pfizer's new vision... Contine Reading & Discuss→
0 Replies
Stories include:
@FierceBiotech: Struggling ARYx terminates staff, vows to get back on track. Article
@JohnCFierce: Impax will get $11.5M upfront and up to $175M in milestones from GSK on Parkinson's drug pact. Contine Reading & Discuss→
0 Replies
WORCESTER, Mass., Dec 17, 2010 (BUSINESS WIRE) — RXi Pharmaceuticals Corporation (Nasdaq: RXII), a recognized leader in RNAi-based therapeutic discovery and development, today announced the selection of its first RNAi therapeutic product candidate to advance into development. Contine Reading & Discuss→
0 Replies
Stories include:
In a rare victory against AIDS, German scientists say that three years after a unique stem cell transplant was tried on a patient, "cure of HIV has been achieved in this" man. This is the first time anyone has been pronounced cured of the disease. But as New... Contine Reading & Discuss→
